- Taylor Vinters, Merlin Place, Milton Rd, Cambridge CB4 0DP
- 26 April 2017
The East of England already has numerous world leading innovation brands present, such as the Cambridge Biomedical Campus, Babraham Institute, the Earlham Institute, the Institute of Food Research, Norfolk and Norwich University Hospital, Addenbrooke’s Hospital, MRC LMB and The Sanger Institute. Some of these are expanding whilst new entrants are also in the pipeline, such as the Cell and Gene Therapy Manufacturing Centre, Public Health England and the Quadrum Institute.
Over the past decades, this base has provided a phenomenal innovation pipeline and spawned many successful new companies that have led to new medicines and technologies that have changed patients’ lives. Surprisingly though, the region has the slowest uptake of innovation into the NHS compared to any other UK region. This when we know market access is a key driver of investment in innovation.
This evening session, a collaboration between One Nucleus and the Eastern Academic Health Science Network, will debate the conundrum of how to ensure patients in the region benefit from the great innovation in a more timely manner.
- Welcome from the Host
- Introduction to One Nucleus
- Introduction to the Eastern Academic Health Science Network
- Panel Discussion - How Can Innovation Reach Our Patients Faster?
, Partner, Taylor Vinters
, Chair EAHSN and Member of the Board of Trustees NHS Providers
, CEO of Health Enterprise East
, Serial Entrepreneur
- Closing Remarks
- Networking over Drinks and Canapés